Silence Therapeutics

SLN

----

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Silence Therapeutics(SLN) predict that the Revenue is 408.74 K (+195.7%), Miss estimate;the EBIT is -15.24 M (+44.88%), Beat estimate;the EPS is -0.435 (-123.5%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

0.00B195.70%

0.00B1376.89%

-0.00B1,181.19%

EBITExceed expectations

-0.02B44.88%

-0.02B41.85%

+0.00B3.03%

EPSMiss expectations

-0.4351123.50%

-0.100248.53%

-0.3349172.03%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD